The pharmaceutical industry of western Germany increased its production to a significant degree last year, according to the industry association, the BPI.
Based on provisional figures, it is regarded as possible that production in 1991 was more than 30 billion Deutschemarks ($18.3 billion) expressed in value terms, according to the association. Figures available for the first eleven months of last year indicate a 16.5% increase in production of 24.3 billion marks ($14.8 billion) worth of the leading drug products, which account for 85% of total pharmaceutical production.
However, the industry's export surplus has narrowed, according to the BPI, with exports advancing by around 14.3% during the period to reach 12 billion marks ($7.3 billion), compared with a 26.3% increase in imports to 7.7 billion marks ($4.7 billion).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze